Martin Decker
Family Medicine · Meadville, PANPI 1831152099
Payments from drug & device makers
Across 427 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Merck$676
- Amgen$560
- Novo Nordisk$516
- Lilly USA, LLC$507
- AbbVie$477
- plus $3K from 28 others
What the payments were for
- Food & beverage$8,620100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 38 | $2,450 |
| Merck | 43 | $676 |
| Amgen | 38 | $560 |
| Novo Nordisk | 36 | $516 |
| Lilly USA, LLC | 31 | $507 |
| AbbVie(2 entities) | 28 | $477 |
| Pfizer | 28 | $469 |
| AstraZeneca | 26 | $374 |
| Johnson & Johnson | 21 | $363 |
| E.r. Squibb & Sons, L.L.C. | 15 | $236 |
| Astellas Pharma US Inc | 12 | $213 |
| Amarin Pharma, Inc. | 25 | $207 |
| Bayer | 11 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $183 |
| Novartis | 9 | $143 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $137 |
| Exact Sciences | 2 | $132 |
| Boehringer Ingelheim | 8 | $120 |
| GSK | 7 | $112 |
| Mylan Specialty L.p. | 1 | $96 |
| Medtronic(2 entities) | 3 | $93 |
| Idorsia Pharmaceuticals US Inc | 3 | $61 |
| Madrigal Pharmaceuticals | 1 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Sanofi Pasteur Inc. | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Viatris Specialty LLC | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
| Biogen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,639 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 78 | $73,828 |
| XareltoRivaroxaban | 56 | $51,229 |
| JardianceEmpagliflozin | 35 | $42,357 |
| JanuviaSitagliptin Phosphate | 22 | $23,892 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $15,180 |
| FarxigaDapagliflozin Propanediol | 22 | $12,800 |
| Atorvastatin Calcium | 241 | $3,056 |
| Metformin Hcl ErMetformin Hcl | 149 | $2,688 |
| Duloxetine Hcl | 81 | $2,516 |
| Niacin ErNiacin | 19 | $2,450 |
| Tamsulosin Hcl | 71 | $2,398 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,349 |
| Lisinopril | 236 | $2,287 |
| Levothyroxine Sodium | 186 | $1,847 |
| Pantoprazole Sodium | 119 | $1,815 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $469 | $73,82878 claims |
| Johnson & JohnsonXarelto | $363 | $51,22956 claims |
| Boehringer IngelheimJardiance | $120 | $42,35735 claims |
| MerckJanuvia | $676 | $23,89222 claims |
| GSKTrelegy Ellipta | $112 | $15,18011 claims |
| AstraZenecaFarxiga | $374 | $12,80022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Meadville
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.